REMINDER: Our user survey closes on Friday, please submit your responses here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
.... you could be sorry you didn't buy before the RNS. And I am holding at least until the Single Cell Protemics Service is up and runnig/
...week and no doubt a bullish update. SP here still unfathomable but keeping the faith in Mariola!
Same today. Makes me wonder when they reveal an excellent year's results and there are solid mass of Buys, how low the SP will tumble!!!!
Yeah sure, they're all buys ?? and yet down she goes....timberrrrr.....
All these sells are buys yet the SP is marked down. Won't shake me out of PRM!
....smells like a medieval London Street, but there's still enough punters here to turn these from losing to winning! Its the new Single Cell Proteomics service starting in Q3 this year which is going to make this leap.
...as many seem to, about the large borrowings. I have taken the view that they are very knowledgeable and have for years and years had confidence in the co'x expertise in their field, which will be rewarded quite soon.
One if the most illiquid shares in the market. Have followed on and off for years. The spread is sometimes 30%. Shame as puts you off buying.
....today with some large deals. Why? Because these are ridiculously cheap even now. Did you read what Mariola said about the planned commencement of a single proteome service? This year? That will be massive. I have always said that the intellectual property value in this outfit is many times its SP, let alone its future earning power. Wish I held more but my portflio is divesrified with some big and boring and others like this. I'm still down on these!
Strong progress and prospects in today's news.
Told you! This is going places - at last.
...on very little business, I anticipate some rather good figures and news imminently which should ga.p up this SP.
...just before the figures and good news. PRM's time has come!
...with tiny amount of trade, wildly underrated and looking forward to figures soon,
...I've done right here. It makes a pleasant change but I am still underwater - just not so much, but might think about it when they hit 10p!
....3-4 weeks away. Better times round the corner for this exciting stock.
and I haven't forgotten Mariela's hope about single cell proteomics.
...so topped up. RNS says more cash in 2022 annual figures so it FALLS!!
A decent slice of RNS news this morning.
...with all the medical progress being made elsewhere of late, that we will hear on or before the Feb update that this little outfit have solved the single cell proteomics conundrum. Even better if they have manged to protect the method by woeldwde patents!
Same again! A mouldy buy of under 30,000 sends us up nearly 10%. I do hope someone reckons Mariola's merry scientists have actually patented a method of isolating a single .proteome. That would add at least 100 million to our valuation - in my (rather ignorant) opinion.
Agreed, investz. Telling in such a lousy market.
Full ASK being paid the past few days ... currently 4.49p.
Looking interesting, following the recent low patch.
proteome isolation, if PRM achieves this and is able to patent the method, will at a stroke, make this into a multi-billion £ stock, because it will open the box to cures for just about all illnesses. Not a lot of people know that!